Comparison of two topical piroxicam and EMLA cream on fistula cannulation pain in hemodialysis patient

Not Applicable

• Conditions: Acute Pain.; Acute pain

• Registration Number: IRCT2013051213301N1
• Lead Sponsor: orestan University of Medical Sciences, Research

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 75

Inclusion Criteria

1. The patient is willing to cooperate and participate in the research.
2. The patient has given informed consent to participate in research.
3. Age is between 18-80 years old.
4. Starting hemodialysis at lease 3 months before.
5. Patients don’t have verbal disability, mental and vision problems.
6. Patients don’t have prior history of mental illness or psychiatric hospitalization.
7. The patient is not addict.
8. The patient has no pain medication dependency.
9. The patient has no pain before cannulation.
10. The patient has not used sedative drugs in the last 24 hours of cannulation .
11. The fistula skin is not injured.
12. Patients don’t have history of G6PD, congenital or idiopathic Methemoglobinemia, liver disease, asthma, skin allergies, dermatitis, rash, thrombophlebitis, gastrointestinal bleeding.
13. Patients don’t have sensitivity to local anesthetic drugs, nonsteroidal anti-inflammatory drugs and other medicines.
14. Patients not be treated with sulfonamide drugs, nitrates and phenobarbital.
Exclusion criteria:
1. Patient does not wish to continue research.
2. The patient is referred to another center.
3. If unsuccessful on the first attempt and repeated cannulation needle into the skin.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The pain of fistula cannulation. Timepoint: firstly without interference - the second after intervention. Method of measurement: visual pain scale.

Secondary Outcome Measures

Name	Time	Method
Short-term effects of topical drugs (piroxicam, EMLA cream and ointment A + D). Timepoint: one hour after the drug. Method of measurement: observed effects.